六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-20-000693 Act: 34 Size: 59 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 8.01 Accession Number: 0001654954-20-013597 Act: 34 Size: 26 KB 网页链接
$Aytu BioScience(AYTU)$ 内部交易: 2020-12-11,Director,ARMISTICE CAPITAL, LLC ,买入,1333334普通股, $6.00
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000919574-20-007541 Size: 10 KB 网页链接
$Aytu BioScience(AYTU)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-20-042741 Act: 34 Size: 2 MB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-20-042738 Act: 34 Size: 2 MB 网页链接
$Aytu BioScience(AYTU)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-20-042392 Act: 33 Size: 576 KB 网页链接
$Aytu BioScience(AYTU)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-20-042390 Act: 34 Size: 381 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001213900-20-042389 Act: 34 Size: 380 KB 网页链接
$Aytu BioScience(AYTU)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001213900-20-042142 Act: 34 Size: 16 KB 网页链接